Daniel Patrick O'Day - 01 Mar 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chairman & CEO, Director
Signature: /s/ Amy Kim by Power of Attorney for Daniel O'Day
Issuer symbol: GILD
Transactions as of: 01 Mar 2023
Net transactions value: -$385,375
Form type: 4
Filing time: 02 Mar 2023, 17:48:31 UTC
Previous filing: 26 Jan 2023
Next filing: 14 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+11,362	+3.2%		364,337	01 Mar 2023	Direct	F1
transaction	GILD	Common Stock	Tax liability	$385,375	-4,842	-1.3%	$79.59	359,495	01 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-11,362	-8.9%		116,051	01 Mar 2023	Common Stock	11,362		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.